|
1
|
Sun KX, Xia HW and Xia RL: Anticancer
effect of salidroside on colon cancer through inhibiting JAK2/STAT3
signaling pathway. Int J Clin Exp Pathol. 8:615–621.
2015.PubMed/NCBI
|
|
2
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA, et al: MiR-9, −31, and −182 deregulation promote proliferation
and tumor cell survival in colon cancer. Neoplasia. 14:868–879.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology. 138:2101–2114
e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nguyen AV, Wu YY, Liu Q, Wang D, Nguyen S,
Loh R, Pang J, Friedman K, Orlofsky A, Augenlicht L, et al: STAT3
in epithelial cells regulates inflammation and tumor progression to
malignant state in colon. Neoplasia. 15:998–1008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamran MZ, Patil P and Gude RP: Role of
STAT3 in cancer metastasis and translational advances. Biomed Res
Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Turkson J, Bowman T, Garcia R, Caldenhoven
E, De Groot RP and Jove R: Stat3 activation by Src induces specific
gene regulation and is required for cell transformation. Mol Cell
Biol. 18:2545–2552. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frank DA: STAT3 as a central mediator of
neoplastic cellular transformation. Cancer Lett. 251:199–210. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akao Y, Nakagawa Y and Naoe T: MicroRNAs
143 and 145 are possible common onco-microRNAs in human cancers.
Oncol Rep. 16:845–850. 2006.PubMed/NCBI
|
|
9
|
Akao Y, Nakagawa Y and Naoe T: let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo C, Sah JF, Beard L, Willson JK,
Markowitz SD and Guda K: The noncoding RNA, miR-126, suppresses the
growth of neoplastic cells by targeting phosphatidylinositol
3-kinase signaling and is frequently lost in colon cancers. Genes
Chromosomes Cancer. 47:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng J, Wang K, Liu X, Chen S and Chen J:
The quantification of tomato microRNAs response to viral infection
by stem-loop real-time RT-PCR. Gene. 437:14–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patel D and Chaudhary J: Increased
expression of bHLH transcription factor E2A (TCF3) in prostate
cancer promotes proliferation and confers resistance to doxorubicin
induced apoptosis. Biochem Biophys Res Commun. 422:146–151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akira S, Nishio Y, Inoue M, Wang XJ, Wei
S, Matsusaka T, Yoshida K, Sudo T, Naruto M and Kishimoto T:
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3
p91-related transcription factor involved in the gp130-mediated
signaling pathway. Cell. 77:63–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu CY, Wang L, Khaletskiy A, Farrar WL,
Larner A, Colburn NH and Li JJ: STAT3 activation is required for
interleukin-6 induced transformation in tumor-promotion sensitive
mouse skin epithelial cells. Oncogene. 21:3949–3960. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shirogane T, Fukada T, Muller JM, Shima
DT, Hibi M and Hirano T: Synergistic roles for Pim-1 and c-Myc in
STAT3-mediated cell cycle progression and antiapoptosis. Immunity.
11:709–719. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhattacharya S, Ray RM and Johnson LR:
STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents
apoptosis in polyamine-depleted cells. Biochem J. 392:335–344.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, Huang C, Huang K, Wu W, Jiang T, Cao
J, Feng Z and Qiu Z: STAT3 knockdown reduces pancreatic cancer cell
invasiveness and matrix metalloproteinase-7 expression in nude
mice. PLoS One. 6:e259412011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dechow TN, Pedranzini L, Leitch A, Leslie
K, Gerald WL, Linkov I and Bromberg JF: Requirement of matrix
metalloproteinase-9 for the transformation of human mammary
epithelial cells by Stat3-C. Proc Natl Acad Sci USA. 101:pp.
10602–10607. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Itoh M, Murata T, Suzuki T, Shindoh M,
Nakajima K, Imai K and Yoshida K: Requirement of STAT3 activation
for maximal collagenase-1 (MMP-1) induction by epidermal growth
factor and malignant characteristics in T24 bladder cancer cells.
Oncogene. 25:1195–1204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Z and Han ZC: STAT3: A critical
transcription activator in angiogenesis. Med Res Rev. 28:185–200.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Q, Briggs J, Park S, Niu G, Kortylewski
M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al:
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by
multiple oncogenic growth signaling pathways. Oncogene.
24:5552–5560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh MK, Park HJ, Kim NH, Park SJ, Park IY
and Kim IS: Hypoxia-inducible factor-1alpha enhances haptoglobin
gene expression by improving binding of STAT3 to the promoter. J
Biol Chem. 286:8857–8865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sullenger BA and Nair S: From the RNA
world to the clinic. Science. 352:1417–1420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Z, He W, Gao J, Luo J, Huang X and Gao
C: Computational prediction and experimental validation of a novel
synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing
mechanisms in cervical cancer. Oncotarget. 6:8019–8035. 2015.
View Article : Google Scholar : PubMed/NCBI
|
